FindTrial
Sign In

Tranexamic acid decreases blood loss during shoulder arthroscopy

Tranexamic acid decreases blood loss during shoulder arthroscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013708
Enrollment
Unknown
Registered
2017-12-05
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder disease

Interventions

1:use tranexamic acid
2:not use tranexamic acid

Sponsors

Wenzhou Central hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients to be scheduled for elective unilateral shoulder arthroscopy, aged 18 years of age, and to be able to give informed consent.

Exclusion criteria

Exclusion criteria: With bleeding or clotting disorder, preoperative anticoagulation therapy, an abnormal coagulation profile, renal insufficiency or disorder, sickle cell disease, allergy to local anesthetics or TXA, severe preoperative swelling

Design outcomes

Primary

MeasureTime frame
Blood loss;—

Countries

China

Contacts

Public ContactHui Chen

The Second Affiliated Hospital, Wenzhou Medical University

chenhui0577@163.com+86 13846574584

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026